[DOI] [PMC free article] [PubMed] [Google Scholar] Voehringer D.W., McConkey D.J., McDonnell T.J., Brisbay S., Meyn R.E
Less muscle also means slower metabolism, which could blunt long-term success and increase the likelihood of rebound weight gain when the medication is stopped
In addition to exogenous supply, the Met salvage pathway is the only Met source
Unlike semaglutide, which activates a single receptor pathway, tirzepatide is a dual GLP-1 and GIP receptor agonist
Similarly, ED platforms focus on younger men dealing with performance concerns, reframing erectile dysfunction as a quality-of-life issue rather than just an older mans treatment for an ordinary mens health problem